Down-regulation of MHC class II molecules and inability to up-regulate class I molecules in murine macrophages after infection with Toxoplasma gondii

Clinical and Experimental Immunology

Volumn 112, Issue 2, 1998, Pages 308-316

  Luder C G K ^a,c   Lang, T ^b   Beuerle, B ^a   Gross, U ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b INSTITUT PASTEUR   (France)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Antigen presenting cells; Immune evasion; MHC antigens; Toxoplasmosis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NITRIC OXIDE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; CELLS, CULTURED; DINOPROSTONE; DOWN-REGULATION; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERFERON TYPE II; INTERLEUKIN-10; KINETICS; MACROPHAGES; MICE; MICE, INBRED BALB C; NITRIC OXIDE; SURFACE PROPERTIES; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 0031782098     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00594.x     Document Type: Article

References (44)

1. Gilbert MJ, Riddell SR, Plachter B et al. Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product. Nature 1996; 383:720-2.
2. Garcia-del Portillo F, Finlay BB. The varied lifestyles of intracellular pathogens within eukaryotic vacuolar compartments. Trends Microbiol 1995; 3:373-80.
3. De Souza Leao S, Lang T, Prina E et al. Intracellular Leishmania amazonensis amastigotes internalize and degrade MHC class II molecules of their host cells. J Cell Sci 1995; 108:3219-31.
4. Jones TC, Hirsch JG. The interaction between Toxoplasma gondii and mammalian cells. The absence of lysosomal fusion with phagocytic vacuoles containing living parasites. J Exp Med 1972; 136:1173-94.
5. Reiner NE, Ng W, McMaster WR. Parasite-accessory cell interactions in murine leishmaniasis. II. Leishmania donovani suppresses macrophage expression of class I and class II major histocompatibility complex gene products. J Immunol 1987; 138:1926-32.
6. Sibley LD, Weidner E, Krahenbuhl JL. Phagosome acidification blocked by intracellular Toxoplasma gondii. Nature 1985; 315:416-9.
7. + T lymphocytes in IFN-γ production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J Immunol 1991; 146:286-92.
8. + T cells in mice. J Immunol 1988; 140:3943-6.
9. Chan J, Siegel JP, Luft BJ. Demonstration of T cell dysfunction during acute Toxoplasma infection. Cell Immunol 1986; 98:422-33.
10. Channon JY, Kasper LH. Toxoplasma gondii-induced immune suppression by human peripheral blood monocytes: role of gamma interferon. Infect Immun 1996; 64:1181-9.
11. Bermudez LE, Covaro G, Remington JS. Infection of murine macrophages with Toxoplasma gondii is associated with release of transforming growth factor-β and downregulation of expression of tumor necrosis factor receptors. Infect Immun 1993; 61:4126-30.
12. Candolfi E, Hunter CA, Remington JS. Mitogen-and antigen-specific proliferation of T cells in murine toxoplasmosis is inhibited by reactive nitrogen intermediates. Infect Immun 1994; 62:1995-2001.
13. Haque S, Khan I, Haque A et al. Impairment of the cellular immune response in acute murine toxoplasmosis: regulation of interleukin 2 production and macrophage-mediated inhibitory effects. Infect Immun 1994; 62:2908-16.
14. Haque S, Haque A, Kasper LH. A Toxoplasma gondii-derived factor(s) stimulates immune downregulation: an in vitro model. Infect Immun 1995; 63:3442-7.
15. Khan IA, Matsuura T, Kasper LH. IL-10 mediates immunosuppression following primary infection with Toxoplasma gondii in mice. Parasite Immunol 1995; 17:185-95.
16. Gross U, Müller WA, Knapp S et al. Identification of a virulence-associated antigen of Toxoplasma gondii by a mouse monoclonal antibody. Infect Immun 1991; 59:4511-6.
17. Lang T, Hellio R, Kaye PM et al. Leishmania donovani-infected macrophages: characterization of the parasitophorous vacuole and potential role of this organelle in antigen presentation. J Cell Sci 1994; 107:2137-50.
18. Antoine J-C, Jouanne C, Lang T et al. Localization of major histocompatibility complex class II molecules in phagolysosomes of murine macrophages infected with Leishmania amazonensis. Infect Immun 1991; 59:764-75.
19. Bhattacharya A, Dorf ME, Springer TA. A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication. J Immunol 1981; 127:2488-95.
20. d antigens on the surface of these cells. Transplantation 1982; 34:113-20.
21. Braunstein NS, Germain RN, Loney K et al. Structurally interdependent and independent regions of allelic polymorphism in class II molecules. Implications for Ia function and evolution. J Immunol 1990; 145:1635-45.
22. 2-microglobulin regulation of cell surface MHC class I conformation and expression. J Immunol 1992; 148:3723-32.
23. Warren MK, Vogel SN. Bone marrow-derived macrophages: development and regulation of differentiation markers by colony-stimulating factor and interferons. J Immunol 1985; 134:982-9.
24. Langermans JAM, van der Hulst MEB, Nibbering PH et al. IFN-γ induced L-arginine dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor alpha. J Immunol 1992; 148:568-74.
25. Sachs L. Angewandte Statistik: Anwendung statistischer Methoden. 6th Edn. Berlin: Springer, 1984.
26. Israelski DM, Araujo FG, Wachtel JS et al. Differences in microbicidal activities of human macrophages against Toxoplasma gondii and Trypanosoma cruzi. Infect Immun 1990; 58:263-5.
27. Murray HW, Scavuzzo D, Jacobs JL et al. In vitro and in vivo activation of human mononuclear phagocytes by interferon gamma: studies with normal and AIDS monocytes. J Immunol 1987; 138:2457-62.
28. Black CM, Bermudez LE, Young LS et al. Coinfection of macrophages modulates interferon-γ and tumor necrosis factor-induced activation against intracellular pathogens. J Exp Med 1990; 172:977-80.
29. Nathan CF, Murray HW, Wiebe ME et al. Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 1983; 158:670-89.
30. + cytotoxic T lymphocytes specific for Toxoplasma gondii lyse tachyzoite-infected target cells. J Immunol 1993; 151:2024-31.
31. + T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells. J Immunol 1991; 147:2310-6.
32. Khan IA, Smith KA, Kasper LH. Induction of antigen-specific human cytotoxic T cells by Toxoplasma gondii. J Clin Invest 1990; 85:1879-86.
33. Fruth U, Solioz N, Louis JA. Leishmania major interferes with antigen presentation by infected macrophages. J Immunol 1992; 150:1857-64.
34. Prina E, Lang T, Glaichenhaus N et al. Presentation of the protective antigen LACK by Leishmania-infected macrophages. J Immunol 1996; 156:4318-27.
35. Leyva-Cobian F, Unanue ER. Intracellular interference with antigen presentation. J Immunol 1988; 141:1445-50.
36. Suzuki Y, Kobayashi A. Macrophage-mediated suppression of immune responses in Toxoplasma-infected mice. I. Inhibition of proliferation of lymphocytes in primary antibody responses. Cell Immunol 1984; 85:417-27.
37. Denkers EY, Scharton-Kersten T, Gazzinelli RT et al. Cell-mediated immunity to Toxoplasma gondii: redundant and required mechanisms as revealed by studies in gene knockout mice. In: Kaufmann SHE, ed. Host responses to intracellular pathogens. Heidelberg: Springer, 1997:167-81.
38. Sklenar I, Jones TC, Alkan S et al. Association of symptomatic human infection with Toxoplasma gondii with imbalance of monocytes and antigen-specific T cell subsets. J Infect Dis 1986; 153:315-24.
39. Glimcher LH, Kara CJ. Sequences and factors: a guide to MHC class-II transcription. Annu Rev Immunol 1992; 10:13-49.
40. Snyder DS, Beller DI, Unanue ER et al. Prostaglandins modulate macrophage Ia expression. Nature 1982; 299:163-5.
41. De Waal Malefyt R, Figdor CG, Huijbens R et al. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes: comparison with IL-4 and modulation by IFN-γ or IL-10. J Immunol 1993; 151:6370-80.
42. Nandan D, Reiner NE. TGF-β attenuates the class II transactivator and reveals an accessory pathway of IFN-γ action. J Immunol 1997; 158:1095-101.
43. Sicher SC, Vasquez MA, Lu CY. Inhibition of macrophage Ia expression by nitric oxide. J Immunol 1994; 153:1293-300.
44. Kwan WC, McMaster R, Wong N et al. Inhibition of expression of major histocompatibility complex class II molecules in macrophages infected with Leishmania donovani occurs at the level of gene transcription via a cyclic AMP-independent mechanism. Infect Immun 1992; 60:2115-20.